|
|
November
21–24, 2002 Barcelona, SPAIN
Officially approved by
the Catalan Goverment to be of interest to health |
| IPEG
Symposium Program |
Friday 22
| 16:00 |
Registration
Symposium |
| 17:00 |
Set
up of posters (Faculty of Medicine)
|
| 18:00 |
IPEG
Board Key Conference: ("Saló
d'Actes", Main entrance of the Hospital)
Pharmaco-EEG:
from cellular to the network level.
EEG b spectral power as a biomarker
for GABAergic inhibition and its role
in the assessment of AEDs
F Lopes da Silva (The Netherlands) |
| 20:30 |
Oral
poster sessions (Faculty
of Medicine) |
Saturday
23
| 8:30-10:00 |
Workshop-1:
Combining multimodal imaging methods
Chair:
Thomas Dierks (Switzerland)
Ulrich Hegerl (Germany)
| 8:30-8:50 |
Functional
correlations between spontaneous
EEG and fMRI
T Köning, D Brandeis , T Dierks
(Switzetland) |
| 8:50-9:10 |
Simultaneous
ERP and event-related fMRI: Focus
on the time-course of brain activity
in target detection
C Mulert, L Jäger , O Pogarell,
P Bussfeld, R Schmitt, G Jucker,
U Hegerl (Germany) |
| 9:10-9:30 |
EEG
and gluocose metabolism (PET)
in dementive disorders
V Jelic, T König , T Dierks, LO
Wahlund (Sweden, Switzerland)
|
| 9:30-9:50 |
The
combination of ERP, transcraneal
mangetic stimulation (TMS) and
fMRI in the study of brain-behaviour
relationships
D Linden, A Sack , D Prvulovic
, D Hubl , K Maurer (Germany,
Switzerland) |
| 9:50-10:00 |
General
discussion |
|
| 10:00-10:30 |
Coffee
Break |
| 10:30-12:00 |
Workshop-2:
New trends in sleep research
Chair:
Peter Anderer (Austria)
Michael Grözinger (Gemany)
| 10:30-10:50 |
Genetic
Programming Approach for the Optimal
Selection of Combinations of Neuronal
Networks to Classify Sleep Stages
by QUISI(R)
R Baumgart-Schmitt R, A Wenzel,
H Danker-Hopfe, WM Herrmann WM
(†) (Germany) |
| 10:50-11:10 |
The
automatic recognition of REM sleep
-a challange and some answers
M Grözinger, J Röschke (Germany)
|
| 11:10-11:30 |
On
the key-lock principle in diagnosis
and treatment of nonorganic insomnia
related to psychiatric disorders:
sleep laboratory investigations
GM Saletu-Zyhlarz, O Arnold, B
Saletu, P Anderer (Austria) |
| 11:30-11:50 |
Unsupervised
continuous sleep analysis based
on single EEG channel
G Gruber, A Flexer, G Dorffner
(Austria) |
| 11:50-12:00 |
General
discussion |
|
| 12:00-13:00 |
Lecture:
Methods in neurophysiological tomography
RD Pascual-Marqui (Switzerland) |
| 13:00-14:30 |
LUNCH
(Faculty of Medicine) |
| 14:30-16:00 |
Workshop-3:
What can be learnt from animal EEG?
Chair:
Gé SF Ruigt (The Netherlands)
Pim Drinkenburg (Belgium)
| 14:30-14:50 |
Animal
Pharmaco-EEG: models, facts and
fallacies. GSF Ruigt (The
Netherlands) |
| 14:50-15:10 |
EEG
parameters as biomarkers: extrapolation
from laboratory animals to humans
M Danhof (The Netherlands) |
| 15:10-15:30 |
Rat
models of genetic absence epilepsy:
what do EEG spike-wave discharges
tell us about drug effects? AML
Coenen, ELJM van Luijtelaar, WHIM
Drinkenburg, CM van Rijn (The
Netherlands, Belgium) |
| 15:30-15:50 |
Signature
profiles in sleep-wake drug discovery
DM Edgar (USA) |
| 15:50-16:00 |
General
discussion |
|
| 16:00-17:30 |
Workshop-4:
Neuropsychiatry and electrophysiology
Chair:
Kinoshita Toshihiko (Japan)
Walter G Sannita (Italy)
| 16:00-16:20 |
Spatial
configuration of brain electric
activity during positive, neutral
and negative emotion
T Isotani, T Kinoshita, D Lehmann,
RD Pascual-Marqui, J Wackermann
(Japan, Switzerland, Germany)
|
| 16:20-16:40 |
Spatial
EEG structure in squizophrenia
S Irisawa, T Isotani, T Kinoshita
(Japan) |
| 16:40-17:00 |
Cholinergic
function and dysfunction in the
visual system
WG Sannita, M Beelke (Italy) |
| 17:00-17:20 |
Sleep
EEG alterations disclose initial
stage of encephalopathy
JM Gaztelu, ME Martino, M Romero-Vives,
J Fernández-Lorente, E de Valiente,
R Bárcena (Spain) |
| 17:20-17:30 |
General
discussion |
|
| 17:30-18:00 |
Coffee
Break |
| 18:00-19:30 |
Oral
presentations (I)
Chair:
Hiroshi Yamadera (Japan)
Jaume Kulisevsky (Spain)
(9
minutes presentation + 4 minutes discussion)
| O-01
|
Effects
of antidepressants on waking behaviour
in the open field and concurrent
EEG in the rat
WHIM Drinkenburg, H van Lier,
AML Coenen (The Netherlands) |
| O-02 |
Antagonism
of PCP EEG changes by classical,
atypical, and new antipsychotic
compounds
C Sebban, B Tesolin-Decros, M
Spedding (France) |
| O-03
|
Effects
of alprazolam on human error detection
and correction using event-related
brain potentials
J Riba, A Rodríguez-Fornells,
TF Münte, MJ Barbanoj (Spain,
Germany) |
| O-04 |
The
efficay of fluvoxamine for poststroke
depression -An evaluation using
event-related potentials topography
Y Kaji, K Hirata, H Tanaka, A
Hozumi, M Arai, Y Kobayashi, T
Kadowaki (Japan) |
| O-05 |
Pre-conscious
phase of visual stimuli processing
in medicated and non-medicated
schizophrenic patients
A Basinska-Starzycka (Poland)
|
| O-06 |
Study
of PSG and carry-over effects
of triazolam and brotizolam with
neurophysiological and subjective
methods
H Yamadera, H Suzuki, K Asayama,
Y Kudo, T Ito, Y Tamura, S Endo
(Japan) |
| O-07 |
Prefrontal
cortex studied with combined TMS
and EEG
S Kähkönen (Finland) |
|
| 19:30 |
IPEG
General Assembly |
Sunday 24
| 8:30-10:00 |
Workshop-5:
Latest advances in the human pharmaco-EEG
Chair:
Werner Herrmann (†)(Germany)
Bernd Saletu (Austria)
| 8:30-8:50 |
Structural
and energetic processes related
to P300: LORETA findings in depression
and effects of antidepressant
drugs
P Anderer, B Saletu, HV Semlitsch,
RD Pascual-Marqui (Austria, Switzerland)
|
| 8:50-9:10 |
Pharmaco-EEG
in the first month of life
Al W de Weerd (The Netherlands)
|
| 9:10-9:30 |
Pharmaco-EEG
in phase I
R Luthringer, PH Boeijinga (France)
|
| 9:30-9:50 |
EEG
topography and tomography in diagnosis
and treatment of mental disorders:
Evidence for a key-lock principle
B Saletu, P Anderer , GM Saletu-Zyhlarz,
RD Pascual-Marqui (Austria, Switzerland)
|
| 9:50-10:00 |
General
discussion |
|
| 10:00-10:30 |
Coffee
Break |
| 10:30-12:00 |
Workshop-6:
Psychiatry
and electrophysiology
Chair:
Silvana Galderisi (Italy)
Werner K Strik (Switzerland)
| 10:30-10:50 |
Monitoring
of disease progression and therapeutic
efficacy in Alzheimer disease
by electrophysiological indices
T Dierks, V Jelic (Switzertand)
|
| 10:50-11:10 |
Identifying
responders to serotonin agonists
by neurolectric brain activity
U Hegerl, O Pogarell, C Mulert,
G Juckel (Germany) |
| 11:10-11:30 |
Predicting
response to antipsychotics by
electrophysiological indices
S Galderisi, P Bucci, A Mucci
(Italy) |
| 11:30-11:50 |
Evoked
Potentials in Psychiatry: psychophysiological
meaning and clinical utility
W Strik (Switzerland) |
| 11:50-12:00 |
General
discussion |
|
| 12:00-13:30 |
Oral
Presentations (II)
Chair:
Peter Boeijinga (France)
Victor Pérez (Spain)
(9
minutes presentation + 4 minutes discussion)
| O-08
|
The
effects of new nootropic drug
on the coherence in adolescents
with idiopatic generalized epilepsy
S Burd, G Avakyan, T Voronina,
T Garibova, E Pinakova, O Badalyan,
V Akimov, A Bogolepova (Russia)
|
| O-09 |
The
predictive value of on-task EEG
for crashes on a driving simulator
task
E de Valck, R Cluydts (Belgium)
|
| O-10
|
Distinctive
effects of modafinil and d-amphetamine
on the homeostatic and circadian
regulation of the human waking
EEG
F Chapotot, R Pigeau, P Naithoh,
A Buguet (France) |
| O-11 |
EEG-mapping
differences between narcolepsy
patients and controls and subsequent
double-blind, placebo-controlled
studies with modafinil
M Saletu, P Anderer, G Saletu-Zyhlarz,
M Mandl, O Arnold, B Saletu (Austria)
|
| O-12 |
Effects
of rivastigmine on lorazepam-induced
changes in EEG: a double-blind,
placebo-controlled study
PH Boeijinga, S Chalon, LA Granier,
L Staner, C Gilles, F Vandenhende,
A Pereira, R Peck, AS Chappell
(France, Belgium, UK, USA) |
| O-13 |
Pharmaco-EEG
monitoring in clinical routine
H Kleinlogel, G Wirtz, R Schläfli
(Switzerland) |
| O-14 |
Brain
activation during emotional processing
identified with LORETA (low resolution
brain electromagnetic tomography):
Localization and dynamics
M Esslen, RD Pascual-Marqui, D
Lehmann (Switzerland) |
|
| 13:30-14:30 |
LUNCH
(Faculty of Medicine) |
| 14:30-15:30 |
Lecture:
Complementary psychometric methods in
pharmaco-EEG research
S Emegbo (UK) |
| 15:30-17:00 |
Workshop-7:
Application of PK/PD modeling approach
to pharmaco-EEG data
Chair:
Manuel-José Barbanoj (Spain)
Rémi Luthringer (France)
| 15:30-15:50 |
Pharmacokinetic/Pharmacodynamic
relationships: Basic concepts
I Trocóniz (Spain) |
| 15:50-16:10 |
Pharmaco-EEG
and PK/PD modeling in drug development:
focus on pre-clinical steps
M Danhof, SAG Visser (The Netherlands)
|
| 16:10-16:30 |
Pharmaco-EEG
and PK/PD modeling in basic research:
focus on human pharmacology
M Valle, MJ Barbanoj, F Jané (Spain)
|
| 16:30-16:50 |
Uses
of pharmaco-EEG and PK/PD modeling
in the clinical scenario
MJ Barbanoj, M Valle, J Kulisevsky,
V Pérez, P Gambús (Spain) |
| 16:50-17:00 |
General
discussion |
|
| 17:00 |
Closing
Remarks and Parexel Grant in memory
of Prof. Werner Herrmann |
Audiovisual
equipment
For Training Course Lectures, Invited Lectures,
Workshops and Oral Presentations we offer
the following equipment:
- Data
projector: For PC projection (Microsoft
Power Point 2000 or older versions) you
may use a floppy disc or CD-Rom in PC-format.
It will be possible to connect your own
laptop.
- Slide
projector: (European standard: 50x50 mm
only). Please ensure that your slides
are clearly labeled and numbered, and
take them to the slide desk prior to your
session.
- Visualiser/Overhead
(Please use A4 portrait only and bring
plain papers as well as transparencies)
It is not possible to use two different
sources at one time.
|
|
IPEG 12th BIENNAL CONGRESS ON PHARMACO-EEG.